MAP2K7 and melanoma: In addition to all these findings, we tested in our in vivo model if the commonly used MEK inhibitor trametinib has an effect on the BRAFV600E mutated A2058 metastatic melanoma cells and if the combination of CBD and THC interferes with trametinib in vivo.